All Insights Conversations Progress Press Preclinical Models Highlight Utility of Peripheral CB1 Inhibition Date published: May 13, 2025 9:00 am PDT Share Copied! Related Documents: Poster: The Sufficiency of Peripheral CB1 Inhibition to Promote Weight Loss At ECO 2025, Skye presented its poster: “Demonstrating the sufficiency of peripheral CB1 inhibition to promote weight loss using clinical pharmacokinetic and pharmacodynamic models.”
